The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer
Clinical trial NCT02539017 · WITHDRAWN
Trial details
- NCT number
- NCT02539017
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.